Tuberculosis and hematopoietic stem cell transplant: Review of a difficult and often underestimated problem

Table 1 Mycobacterium Tuberculosis infections after allogeneic stem cell transplantation

Ref.	Country	Patients with	TB incidence	Site of
	(period of	TB/No. of	in general	infection (n)
	study)	HSCT	population (%)
Navari et al[20]	United States (1983)	2/682	0.014-0.03	Lung
Kurzrock et al[21]	United States (1984)	2/90	0.014-0.03	Lung
Roy et al[8]	United States (1974-1994)	11/2241	0.014-0.03	Lung (1), EP (11)
Ip et al[22]	Hong Kong (1991-1994)	10/183	5.5	Lung
Aljurf et al[23]	Saudi Arabia (1986-1997)	4/641	0.62	Lung, CNS, spine
Budak-Alpdogan et al[19]	Turkey (1988-1998)	5/351	1.42	Lung (4), renal (1)
de la Cámara et al[11]	Spain (2000)	12/2866	0.41	Lung
Ullah et al[24]	Pakistan (2001-2006)	4/154	2.6	Lung (3), EP (1)
George et al[25]	India (1986-2001)	9/304	2.3	Lung (2), EP (7)
Lee et al[26]	South Korea (1996-2003)	9/295	3.1	Lung (8), EP (1)
Ullah et al[27]	Pakistan (2002-2007)	2/37	5.4	Lung
Shima et al[28]	Japan (2009)	Case report	-	EP

TB: Tuberculosis; HSCT: Hematopoietic stem cell transplantation; EP: Extrapulmonary; CNS: Central nervous system.